Related Experiment Video
Updated: Jun 5, 2025

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Cancer stem cells targeted therapy: A changing concept in head and neck squamous cell carcinoma
Adesh S Manchanda1, Harmandeep K Rai2, Manvir Kaur2
1Department of Oral and Maxillofacial Pathology, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India.
Abstract:
Identification of cancer stem cells (CSCs), their multilineage potential, and their ability of self-renewal have revolutionised the current concepts of cancer treatment. The suspected role of CSCs in cancer initiation, progression and relapse with the observed resistance to conventional cancer treatments has led to the development of more specific and targeted therapies. Identification of the properties of stem cells (SCs) and their potential for localisation in cancer has made targeted anti-cancer treatment possible by incorporating some modifications into these SCs. The same concept has been applied to the treatment strategy for head and neck squamous cell carcinoma (HNSCC) to control the relapse and improve the mortality rates in patients. This review aims to discuss the role of CSCs in the course and relapse of HNSCC, various surface markers for their identification and SC-targeted therapy options for the treatment of HNSCC, with a highlight on the advantages, shortcomings, opportunities and challenges to SC therapy in head and neck squamous cell carcinoma, treatment and scope for future research.
Insights
Cancer stem cells (CSCs) drive cancer initiation and relapse, prompting targeted therapies. This review explores CSCs in head and neck squamous cell carcinoma (HNSCC), focusing on identification and SC-targeted treatments.
Area of Science:
- Oncology
- Stem Cell Biology
- Head and Neck Cancer Research
Background:
- Cancer stem cells (CSCs) possess self-renewal and multilineage potential, revolutionizing cancer treatment concepts.
- CSCs are implicated in cancer initiation, progression, relapse, and resistance to conventional therapies.
- Understanding stem cell (SC) properties and localization in cancer enables targeted therapeutic strategies.
Purpose of the Study:
- To review the role of CSCs in the development and relapse of head and neck squamous cell carcinoma (HNSCC).
- To discuss surface markers for CSC identification in HNSCC.
- To explore SC-targeted therapy options for HNSCC, including advantages, challenges, and future research directions.
Main Methods:
- Literature review focusing on CSCs in HNSCC.
- Analysis of studies identifying CSC surface markers.
- Evaluation of current and emerging SC-targeted therapeutic approaches for HNSCC.
Main Results:
- CSCs play a significant role in HNSCC initiation, progression, and recurrence.
- Specific surface markers aid in the identification and isolation of HNSCC CSCs.
- SC-targeted therapies offer potential for improved HNSCC treatment outcomes, despite existing challenges.
Conclusions:
- Targeting CSCs is a promising strategy for managing HNSCC and reducing patient mortality.
- Further research into CSC biology and targeted therapies is crucial for advancing HNSCC treatment.
- Addressing the challenges of SC-targeted therapy will be key to its successful clinical application in HNSCC.
More Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Inhibition of Cdk Activity